Incannex Healthcare Files 8-K
Ticker: IXHL · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, pharmaceuticals
TL;DR
Incannex Healthcare filed an 8-K on April 3, 2025. Nothing major, just standard reporting.
AI Summary
Incannex Healthcare Inc. filed an 8-K on April 3, 2025, reporting other events and financial statements. The company, formerly Incannex Healthcare Ltd until July 20, 2021, is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides an update on Incannex Healthcare's corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing appears to be routine corporate reporting and does not indicate any significant new risks or material events.
Key Numbers
- 001-41106 — SEC File Number (Identifies the company's filing with the SEC.)
- 25807547 — Film Number (Internal SEC processing number.)
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- Incannex Healthcare Ltd (company) — Former company name
- April 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of April 3, 2025.
When was Incannex Healthcare Inc. formerly known as Incannex Healthcare Ltd?
The company was formerly known as Incannex Healthcare Ltd until July 20, 2021.
In which state is Incannex Healthcare Inc. incorporated?
Incannex Healthcare Inc. is incorporated in Delaware.
What is the Standard Industrial Classification code for Incannex Healthcare Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the principal executive office address and phone number listed?
The principal executive offices are located at Suite 105, 8 Century Circuit, Norwest, NSW 2153, Australia, and the phone number is +61 409 840 786.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding Incannex Healthcare Inc. (IXHL).